JPMorgan Healthcare Leaders ETF
Open-end / ETFRegistrant
J.P. Morgan Exchange-Traded Fund Trust
Class ticker
Net Assets
$9,074,769
Holdings
61
Latest Report
Jul 31, 2026
Net Assets Over Time
Holdings · 61
Export CSV
Showing 1–50
of 61 holdings by value
· page 1 of 2
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
| AbbVie, Inc. | ABBV | 2,838 | $712,168 | 7.85% | Long | EC | |
| Eli Lilly & Co. | LLY | 613 | $704,239 | 7.76% | Long | EC | |
| UnitedHealth Group, Inc. | UNH | 1,281 | $530,846 | 5.85% | Long | EC | |
| Merck & Co., Inc. | MRK | 3,359 | $437,342 | 4.82% | Long | EC | |
| Johnson & Johnson | JNJ | 1,706 | $437,333 | 4.82% | Long | EC | |
|
AstraZeneca plc
|
— | 2,007 | $341,411 | 3.76% | Long | EC | |
| Thermo Fisher Scientific, Inc. | TMO | 590 | $338,837 | 3.73% | Long | EC | |
| Bristol-Myers Squibb Co. | BMY | 4,962 | $324,068 | 3.57% | Long | EC | |
| Abbott Laboratories | ABT | 2,669 | $282,113 | 3.11% | Long | EC | |
| CVS Health Corp. | CVS | 2,458 | $256,689 | 2.83% | Long | EC | |
|
Roche Holding AG
|
— | 586 | $256,136 | 2.82% | Long | EC | |
|
Novo Nordisk A/S
|
— | 5,014 | $237,170 | 2.61% | Long | EC | |
|
GSK plc
|
— | 8,605 | $223,755 | 2.47% | Long | EC | |
| Stryker Corp. | SYK | 620 | $201,934 | 2.23% | Long | EC | |
| Danaher Corp. | DHR | 1,006 | $196,150 | 2.16% | Long | EC | |
| Cencora, Inc. | COR | 604 | $188,049 | 2.07% | Long | EC | |
|
Argenx SE
|
— | 218 | $186,716 | 2.06% | Long | EC | |
| Intuitive Surgical, Inc. | ISRG | 496 | $175,252 | 1.93% | Long | EC | |
| Edwards Lifesciences Corp. | EW | 1,827 | $157,250 | 1.73% | Long | EC | |
| IQVIA Holdings, Inc. | IQV | 661 | $155,348 | 1.71% | Long | EC | |
|
Teva Pharmaceutical Industries Ltd.
|
— | 4,084 | $145,306 | 1.60% | Long | EC | |
| Regeneron Pharmaceuticals, Inc. | REGN | 190 | $144,900 | 1.60% | Long | EC | |
|
Novartis AG
|
— | 926 | $144,819 | 1.60% | Long | EC | |
| Biogen, Inc. | BIIB | 699 | $141,862 | 1.56% | Long | EC | |
| Cardinal Health, Inc. | CAH | 597 | $137,328 | 1.51% | Long | EC | |
|
Takeda Pharmaceutical Co. Ltd.
|
— | 3,400 | $116,741 | 1.29% | Long | EC | |
| Centene Corp. | CNC | 1,740 | $108,263 | 1.19% | Long | EC | |
|
Hoya Corp.
|
— | 700 | $107,042 | 1.18% | Long | EC | |
| Humana, Inc. | HUM | 290 | $105,519 | 1.16% | Long | EC | |
| Boston Scientific Corp. | BSX | 2,069 | $96,684 | 1.07% | Long | EC | |
|
Fresenius SE & Co. KGaA
|
— | 1,831 | $94,108 | 1.04% | Long | EC | |
| Insmed, Inc. | INSM | 894 | $88,148 | 0.97% | Long | EC | |
|
Genmab A/S
|
— | 263 | $75,702 | 0.83% | Long | EC | |
|
Sartorius AG
|
— | 298 | $75,106 | 0.83% | Long | EC | |
| Dyne Therapeutics, Inc. | DYN | 2,968 | $74,734 | 0.82% | Long | EC | |
| Vertex Pharmaceuticals, Inc. | VRTX | 155 | $73,951 | 0.81% | Long | EC | |
| Spyre Therapeutics, Inc. | SYRE | 710 | $69,814 | 0.77% | Long | EC | |
| Neurocrine Biosciences, Inc. | NBIX | 399 | $66,553 | 0.73% | Long | EC | |
| Bridgebio Pharma, Inc. | BBIO | 822 | $65,834 | 0.73% | Long | EC | |
| Alnylam Pharmaceuticals, Inc. | ALNY | 311 | $63,917 | 0.70% | Long | EC | |
| Align Technology, Inc. | ALGN | 376 | $63,604 | 0.70% | Long | EC | |
| Charles River Laboratories International, Inc. | CRL | 259 | $60,220 | 0.66% | Long | EC | |
| CG oncology, Inc. | CGON | 791 | $56,311 | 0.62% | Long | EC | |
|
Ascendis Pharma A/S
|
— | 218 | $53,172 | 0.59% | Long | EC | |
| Alumis, Inc. | ALMS | 1,834 | $51,811 | 0.57% | Long | EC | |
| LB Pharmaceuticals, Inc. | LBRX | 1,258 | $50,421 | 0.56% | Long | EC | |
| Disc Medicine, Inc. | IRON | 600 | $46,200 | 0.51% | Long | EC | |
| PTC Therapeutics, Inc. | PTCT | 658 | $44,751 | 0.49% | Long | EC | |
| Bicara Therapeutics, Inc. | BCAX | 1,484 | $40,216 | 0.44% | Long | EC | |
| Arcus Biosciences, Inc. | RCUS | 1,384 | $39,015 | 0.43% | Long | EC |
Showing the top 50 of 61 holdings. Create a free account to see every holding and download the CSV.